MultiPlan Appoints C. Martin Harris, MD, MBA to its Board of Directors
MultiPlan Corporation (MultiPlan) (NYSE: MPLN), a market-leading, technology-enabled provider of end-to-end healthcare cost management solutions, today announced the appointment of C. Martin, Harris, MD, MBA to its Board of Directors as a new independent director, effective January 1, 2021.
- MultiPlan Corporation (MultiPlan) (NYSE: MPLN), a market-leading, technology-enabled provider of end-to-end healthcare cost management solutions, today announced the appointment of C. Martin, Harris, MD, MBA to its Board of Directors as a new independent director, effective January 1, 2021.
- Holding an MD and an MBA, Dr. Harris has over two decades of experience in medicine and innovative application of technology.
- With his interdisciplinary background and extensive experience, Dr. Harris brings a unique blend of medical, technical and strategic expertise to MultiPlans Board.
- "We are pleased to welcome Dr. Harris to the MultiPlan Board," said Mark Tabak, CEO and chairman of MultiPlan.